West Virginia University Mary Babb Randolph Cancer Center Selects OnCore® as it's Clinical Research Informatics Platform
MADISON, Wis. (April 14, 2009) — On April 1st, PercipEnz received the signed contract for OnCore from the West Virginia University Mary Babb Randolph Cancer Center (MBRCC).
With the signing of the contract for the OnCore Clinical Research Management system (OnCore CRM), the MBRCC has become the 24th cancer center to adopt the OnCore platform in support of its clinical research informatics needs. OnCore is the most widely adopted informatics platform among cancer centers nationwide and is used by one out of every four NCI-designated cancer centers.
The MBRCC is West Virginia's most comprehensive cancer treatment, research and education facility. The center offers a multidisciplinary team approach and state of the art technologies and treatments, as well as the latest clinical trials and a variety of education and prevention outreach programs.
The Cancer Center, operated by WVU Hospitals, houses the NCI's Mid-Atlantic Cancer Information Service, the Betty Puskar Breast Care Center and the Blood and Marrow Transplant / Hematologic Malignancy Program. For more information, visit the MBRCC website at: www.hsc.wvu.edu/mbrcc/
The OnCore system is the flagship product of PercipEnz Technologies, Inc., a software development company specializing in clinical and translational research informatics for midsized to large organizations.



Exchange